Clinical management and evidence based treatment of chronic hepatitis C--12th European Congress of Clinical Microbiology and Infectious Diseases, Milan, Italy, 21-24 April 2002.
As in totally 1% of the worldwide population is afflicted by hepatitis C virus with most of the 200 Mio carriers not diagnosed or treated, the clinical management of chronic hepatitis C remains an urgent demand for global health. The 12th European Congress of Clinical Microbiology and Infectious Diseases (12th ECCMID) held in Milan, Italy, from 21 to 24 April 2002, focussed on viral hepatitis in a keynote lecture as well as a session on evidence based treatment of chronic infection and various poster presentations.
ESSEX Pharma GmbH München, Tannenstr. 15a, D-42653 Solingen, Germany. gudrun.tossing@essex.de
Gudrun
G
Tossing
D000998:Antiviral Agents / Q000627:therapeutic use*; D019317:Evidence-Based Medicine; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans
D000998:Antiviral Agents